| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 746 | 758 | 795 | 995 | 389 | 552 | 1.869 | 871 | 1.155 | 491 |
| Total Income - EUR | 746 | 758 | 795 | 995 | 389 | 552 | 1.869 | 871 | 1.155 | 491 |
| Total Expenses - EUR | 360 | 559 | 312 | 5.089 | 4.188 | 215 | 832 | 410 | 521 | 512 |
| Gross Profit/Loss - EUR | 386 | 198 | 483 | -4.093 | -3.799 | 336 | 1.037 | 461 | 634 | -20 |
| Net Profit/Loss - EUR | 366 | 175 | 460 | -4.124 | -3.811 | 320 | 981 | 435 | 634 | -20 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biosic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.847 | 4.715 | 5.357 | 3.432 | 5.016 | 4.781 | 3.303 | 2.226 | 1.205 | 1.365 |
| Inventories | 3.613 | 3.637 | 4.272 | 1.521 | 2.483 | 2.458 | 1.217 | 0 | 0 | 0 |
| Receivables | 1.187 | 877 | 904 | 1.211 | 2.308 | 1.707 | 1.485 | 1.126 | 974 | 947 |
| Cash | 47 | 202 | 181 | 701 | 225 | 616 | 601 | 1.100 | 231 | 418 |
| Shareholders Funds | 533 | 703 | 1.151 | -2.994 | -6.747 | -6.299 | -5.178 | -4.759 | -4.111 | -4.109 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.313 | 4.012 | 4.206 | 6.426 | 11.763 | 11.080 | 8.481 | 6.985 | 5.316 | 5.474 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Biosic Srl